1 2 3 4 5 6 7 8 9 10 Next >>

Consider Antitrust in Apokyn Generic Case: FTC 03/22/2023

Complete Response for AbbVie Parkinson’s NDA 03/22/2023

Registry Set Up for Breast Implant Carcinoma Reports 03/22/2023

Contradictory Info in P&G Nyquil Filing: FDA 03/22/2023

Steps Needed to Address Drug Shortages: Report 03/22/2023

Ways to Increase Clinical Trial Diversity: PhRMA 03/22/2023

Roche/Lilly Collaborate on Alzheimer’s Test 03/22/2023

Biological Product Deviation Reports Up: CBER 03/22/2023

Regulators Need to Keep Up with ‘Patient Influencers’: Study 03/22/2023

Sandoz sBLA for Citrate-free Hyrimoz 03/21/2023

ICH Approves Gene Therapy S12 Guidance 03/21/2023

Changes Suggested for Cancer Drug Dosing Guidance 03/21/2023

‘Significant’ CGMP Violations at Dunagin Pharmaceuticals 03/21/2023

Multiple Violations at Contract Manufacturer 03/21/2023

Turn Gene Therapy into Reality: Marks 03/21/2023

CDER’s Requests for Intarcia Hearing 03/21/2023

Drug Promotion Research Landscape Analyzed 03/21/2023

Brainomix AI Stroke Tool Cleared by FDA 03/21/2023

Viz.ai Algorithm Cleared for Abdominal Aneurysms 03/21/2023

Accelerated Approval Mulled for Biogen’s Tofersen 03/20/2023

Guide on Pharmacogenomic Data Submissions 03/20/2023

FDA Input on Rare Disease Development Needed: PhRMA 03/20/2023

Keep Device Real-World Evidence Under NESTcc: MDMA 03/20/2023

Athenex Cell Therapy on Clinical Hold 03/20/2023

Remote Assessments May Be Model for Device Inspections 03/20/2023

Sarepta BLA Needs Panel Review: FDA 03/17/2023

Guide on Pharmacogenomic Data Submissions 03/17/2023

FDA Hits Olympus with Warning Letter 03/17/2023

CDER Posts Annual Office of Compliance Report 03/17/2023

Datascope’s Cardiosave Heart Pumps Recalled 03/17/2023

Ipsen NDA Resubmission for Palovarotene 03/17/2023

Medical Foods Q&A Guidance 03/16/2023

Drug Supply Guide on Illegitimate/Suspect Products 03/16/2023

FDA Clears BD Vaginitis Test 03/16/2023

Glaxo MenABCWY Vaccine Hits 11 Endpoints 03/16/2023

IPRP Cell/Gene Therapy Raw Materials Paper 03/16/2023

Senate Appropriators Announce 4/19 FDA Budget Hearing 03/16/2023

Panel Votes to Support Paxlovid NDA Approval 03/16/2023

Community Should Push AA Drug Studies: Califf 03/16/2023

Clinical Investigation Electronic Systems Guidance 03/15/2023

Bill to Streamline Generic Drug Approvals 03/15/2023

Former Drug Sales Rep Pleads Guilty 03/15/2023

FDA Reviewers Seem Positive on Paxlovid NDA 03/15/2023

Mixed Stakeholder Views on Orange Book Listings 03/15/2023

PhRMA Comments on Drug Labeling Guidance 03/15/2023

Janssen Vaccine Warning on Myocarditis/Pericarditis 03/15/2023

FDA Clears Telehealth Respiratory Wheeze Detector 03/15/2023

Profounda ‘Significant’ CGMP Violations 03/14/2023

House GOP Probes Covid ‘Political Interference’ at FDA 03/14/2023

More Comments on Patent Office/FDA Collaboration 03/14/2023

Characterizing MRD Data in Cancer Trials 03/14/2023

Petition Against BD’s Breast Reconstruction Device 03/14/2023

CGMP Violations at Formology Lab 03/14/2023

‘Objectionable Conditions’ at Avanti Study Site: FDA 03/14/2023

FDA Webview Reaches Out for Your Guidance 03/13/2023

FDA Clears PeekMed Orthopedic Surgery Planner 03/13/2023

Most Drug Shortages are Manufacturing Related: FDA 03/13/2023

FDA Clinical Hold on Mersana Tumor Drug 03/13/2023

Guide on Gastric pH-Dependent Drug Interactions 03/13/2023

FDA/CDC Correct Florida Official’s Vaccine ‘Misinformation’ 03/13/2023

Panel to Review Entasis Therapeutics NDA 03/10/2023

GAO Report Hits FDA on Advanced Manufacturing Tracking 03/10/2023

FDA Outlines Disposition of Covid-19 Guidances 03/10/2023

Pfizer NDA for Migraine Nasal Spray OK’d 03/10/2023

18 Senators Want End to Accelerated Approval Pricing Model 03/10/2023

Baxter Device Correction for Life2000 Ventilator 03/10/2023

FDA, EMA Parallel Scientific Advice is Effective: Study 03/09/2023

Lilly Drops Solanezumab on Negative Results 03/09/2023

How Can FDA Combat Medical Misinformation? 03/09/2023

FDA Seeks $372 Million (10%) Budget Boost for FY 2024 03/09/2023

Former Stimwave CEO Indicted 03/09/2023

FDA Updates EUA Listing for Medical Devices 03/09/2023

Mesoblast Remestemcel-L BLA Resubmitted 03/08/2023

Updated Safety Alert on Breast Implant Cancer 03/08/2023

FDA Accepts BioMarin Voxzogo New Indication sBLA 03/08/2023

Covis Willing to Voluntarily Withdraw Makena 03/08/2023

FDA’s Cancer Patient-Focused Glossary 03/08/2023

USP Launches Nitrosamines Analytical Hub 03/08/2023

FDA Bioresearch Inspection Findings Out 03/08/2023

Determine NMN is a Dietary Supplement: Petition 03/08/2023

Lithium Citrate Not Withdrawn Due to Safety/Efficacy 03/07/2023

FDA Extends Review Date for BioMarin’s Roctavian 03/07/2023

FDA Highlights ‘Proactive and Innovative’ Opioid Research 03/07/2023

Thomas Advanced Medical Illegally Selling HCT/Ps: FDA 03/07/2023

FDA Withdraws Fosun ANDA for Pemoline 03/07/2023

Abbott Alinity I Concussion Blood Test Cleared 03/07/2023

Update Accelerated Approval Labels with Required Info: Study 03/07/2023

More Hemodialysis Toxic Compound Analysis Needed: FDA 03/07/2023

FDA Grants De Novo Device for Tinnitus 03/07/2023

Aclaris Skin Condition Study Misses Endpoint 03/07/2023

Some Guidance Changes Helpful, More Needed: AAM 03/07/2023

Dupixent sBLA for Chronic Spontaneous Urticaria 03/07/2023

Questions on Oncologic Investigational Agent Guidance 03/07/2023

Incyte Abandons Phase 3 Myelofibrosis Trial 03/06/2023

FreeStyle Sensors for Automated Insulin Delivery 03/06/2023

FDA Increasing Oversight on Diethylene Glycol Contamination 03/06/2023

Novartis Petitions FDA on Dosing Titration Info Requirement 03/06/2023

‘Priority’ for Alzheimer’s sBLA Seeking Traditional Approval 03/06/2023

DoJ Preferring Deferred Prosecution Agreements: Attorneys 03/06/2023

Veru EUA Request for Covid Drug Denied 03/03/2023

1 2 3 4 5 6 7 8 9 10  Next >>